title: [Evaluation of treatment of iron deficiency anemia in pregnancy].
abstract: BACKGROUND
  Pregnancy is a condition that predisposes women to anemia, a problem which is easily solved with the identification of susceptible patients and with proper treatment.
  
  
  OBJECTIVE
  To determine the prevalence of anemia in the study group, the characteristics of the patients, and assess the impact of iron therapy in anemic pregnant women.
  
  
  METHODS
  A retrospective study was done in 98 pregnant patients who attended a medical office in San Luis Potosi, S.L.P, between 2010 and 2011. The studied variables were: hemoglobin and hematocrit concentration for anemia diagnosis. Statistical analysis was performed using Epi Info-7 for the association between variables.
  
  
  RESULTS
  The prevalence of anemia found in the study was 4.08% in the first weeks of gestation. 75% of those patients were overweight or obese, and as the pregnancy progressed prevalence increased to 16.32%. The patients whose anemia was detected between weeks 28-33 of gestation had 4.58 times the risk of having it than those who were detected in the first trimester (p < .05). While anemia was more frequent among women with overweight or obesity 5% (n = 3), no statistically significant difference with normal weight women was observed in early pregnancy.
  
  
  CONCLUSIONS
  The prevalence of anemia increased as pregnancy progressed, therefore It is necessary that the physician requests the patient 3 or 4 blood studies to keep adequate prenatal care and have the opportunity for early detection of anemia.
authors: Colegio de Ginecología y Obstetricia de San Luis Potosi, SC. fofarrill@prodigy.net.mx
authors: Fernando
authors: F
authors: O'Farrill-Santoscoy
authors: Marcela
authors: M
authors: O'Farrill-Cadena
authors: Lilia Esperanza
authors: LE
authors: Fragoso-Morales
mesh_terms: D000293:Adolescent; D000328:Adult; D018798:Anemia, Iron-Deficiency / Q000097:blood / Q000188:drug therapy* / Q000453:epidemiology; D001835:Body Weight; D018450:Disease Progression; D005260:Female; D005492:Folic Acid / Q000627:therapeutic use*; D006400:Hematocrit; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007501:Iron / Q000627:therapeutic use*; D008423:Maternal Age; D008800:Mexico / Q000453:epidemiology; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000097:blood / Q000188:drug therapy* / Q000453:epidemiology; D011264:Pregnancy Trimesters; D015995:Prevalence; D012189:Retrospective Studies; D055815:Young Adult
chemical_list: D006454:Hemoglobins; D005492:Folic Acid; D007501:Iron